Multilevel regulation and molecular mechanism of poly (rC)-binding protein 1 in cancer

Xuetian Zhang1,2,3,4, Cuixia Di1,2,3,4, Yuhong Chen1,2,3,4

  • 1Bio-Medical Research Center, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.

Insights

Poly (rC)-binding protein 1 (PCBP1) acts as a tumor suppressor, inhibiting cancer progression and metastasis. Understanding its regulatory roles in gene expression and cancer cell processes offers new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Poly (rC)-binding protein 1 (PCBP1) is a 38 kDa RNA/DNA-binding protein.
  • PCBP1 is frequently downregulated in various cancer types.
  • Evidence suggests PCBP1 functions as a tumor suppressor, inhibiting cancer initiation, progression, and metastasis.

Purpose of the Study:

  • To review the multifaceted regulatory functions of PCBP1 in cancer.
  • To summarize PCBP1's inhibitory effects on common tumors.
  • To elucidate PCBP1's molecular mechanisms in cancer, including its roles in hypoxic microenvironments, autophagy, apoptosis, and chemotherapy.

Main Methods:

  • Literature review of existing research on PCBP1 in cancer.
  • Analysis of PCBP1's regulatory roles in gene transcription, alternative splicing, and translation.
  • Synthesis of data on PCBP1's involvement in cancer cell biology and response to therapy.

Main Results:

  • PCBP1 regulates gene transcription, alternative splicing, and translation of cancer-related genes.
  • PCBP1 exhibits inhibitory effects against a range of common tumors.
  • PCBP1 plays significant roles in the hypoxic microenvironment, autophagy, apoptosis, and chemotherapy response in cancer cells.

Conclusions:

  • PCBP1 exhibits diverse tumor-suppressive functions.
  • Further investigation into PCBP1's molecular mechanisms is crucial for developing novel cancer therapies.
  • Targeting PCBP1 may offer a promising avenue for cancer treatment.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

1.9K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K